Skip to main content
    M

    Mainz Biomed BV (MYNZ)

    Official site

    DIAGNOSTICS & RESEARCH

    $1.03
    -0.09 (-8.04%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(8/14)
    Avg Surprise
    -936.38%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 28
    		$0.00N/A+100.00%Beat+100.0%
    Jun 25
    Reported Sep 3
    		$-2.65$-2.40-10.42%Miss-
    Mar 25
    Reported May 30
    		$-7.71$-2.80-175.36%Miss-3112.5%
    Dec 24
    Reported Mar 31
    		$-7.71$-6.40-20.47%Miss-3112.5%
    Sep 24
    Reported Oct 21
    		$-19.60$-0.15-12966.67%Miss-4925.6%
    Jun 24
    Reported Jun 30
    		$N/A$-9.00N/ABeat-
    Mar 24
    Reported Apr 9
    		$-0.24$-0.32+25.00%Beat+46.7%
    Dec 23
    Reported Mar 6
    		$-0.24$-0.32+24.22%Beat+47.8%
    Sep 23
    Reported Nov 16
    		$-0.39$-0.47+17.02%Beat+9.3%
    Jun 23
    Reported Aug 15
    		$-0.56$-0.42-33.33%Miss-21.7%
    Mar 23
    Reported Apr 27
    		$-0.45$-0.46+2.17%Beat+46.4%
    Dec 22
    Reported Mar 8
    		$-0.46$-0.46+0.00%Beat-1433.3%
    Sep 22
    Reported Nov 2
    		$-0.43$-0.43+0.00%Beat-2050.0%
    Jun 22
    Reported Sep 7
    		$-0.46$-0.46+0.00%Beat-284.0%
    Mar 22
    Reported May 2
    		$-0.84$-0.49-71.43%Miss-
    Dec 21
    Reported Jan 28
    		$-0.03$0.00N/AMiss-
    Sep 21
    Reported Nov 12
    		$-0.02$0.00N/AMiss-
    Mar 21
    Reported Jun 30
    		$-0.12$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.11xFCF Yield-888.59%
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.52xQuick Ratio0.43x
    Trading Statistics
    BetaN/AAvg Volume497.38K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.27
    SMA 20$1.30
    SMA 50$1.37
    SMA 200$1.23
    EMA 10$1.22
    EMA 20$1.28
    EMA 50$1.34
    EMA 200$1.39

    MACD

    Line: -0.06Signal: -0.03Hist: -0.03

    ADX

    ADX: 19.0+DI: 11.7-DI: 34.3

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down92.0
    PSAR$1.48

    Bollinger Bands

    Upper Band$1.52
    Lower Band$1.08
    %B Position3399%(Upper)
    Band Width-0.11

    RSI (14-Day)

    Neutral
    35.1

    Momentum Oscillators

    Stoch %K26.7
    Stoch %D32.9
    Williams %R-78.3
    ROC (10d)-21.4%
    Momentum-0.28
    CCI (20d)-239.8
    MFI (14d)60.6

    Volatility Measures

    ATR (14d)$0.12(11.6%)
    StdDev (20d)0.11
    Hist Vol111.9%(High)

    Volume Flow

    VWAP$1.04
    OBV925.3M
    AD Line131.7M
    CMF (20d)-0.021

    Volume Metrics

    Avg Vol (20d)504.3K
    Vol Ratio0.7x
    VWMA (20d)$1.27

    Pivot Points

    R3$1.27
    R2$1.20
    R1$1.16
    Pivot Point$1.09
    S1$1.05
    S2$0.98
    S3$0.94

    Advanced Oscillators

    TSI-15.45
    Ultimate Osc41.1
    KST-79.83

    Financial Data

    QuarterJun 2025Dec 2024Sep 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Total Revenue$286,717$373,218$520,773$214,761$214,761$181,669$500,208$251,397$144,337$96,791$278,480$160,037
    Cost of Revenue$597,058$117,373$201,735$163,494$80,027$94,483$222,326$217,988N/A$78,178$129,738$334,954
    Gross Profit$-310,341$255,845$319,038$40,251$134,734$87,186$277,882$33,409N/A$18,613$148,742$-174,917
    Operating Expenses$7.78M$9.14M$10.13M$13.90M$7.01M$5.73M$13.25M$12.45M$8.48M$5.49M$13.91M$11.08M
    R&D$2.77M$2.60M$3.24M$3.85M$2.00M$1.85M$5.25M$2.96M$0$909,003$696,288$260,543
    SG&A$2.88M$3.56M$4.52M$3.53M$4.78M$2.75M$4.82M$7.37M$2.35M$3.98M$10.46M$8.23M
    Operating Income$-8,091,348$-8,888,080$-9,807,328$-12,231,036$-6,800,018$-5,640,638$-12,975,112$-12,278,938N/A$-5,475,593$-13,895,816$-9,469,972
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$215,260$1.08M$659,473$662,861$0$659,119$146,720$289,324$0$120,634$60,382$84,792
    Income Before Tax$-8,344,211$-10,626,901$-11,023,762$-5,183,327$-5,183,327$-6,299,757$-13,121,832$-12,509,914$0$-5,596,227$-13,877,422$-11,428,377
    Income Tax Expense$0$0$0$1.97M$0$0$146,720$-213,143$0$0$278,532$84,792
    Net Income$-8,344,211$-10,626,901$-11,023,762$-5,183,327$-5,183,327$-6,299,757$-13,268,552$-12,575,303N/A$-5,596,227$-13,877,422$-11,428,377
    EBITDA$-7,743,485$-10,087,211$-9,471,180$-12,610,796N/A$-5,437,064$-12,400,408$-11,877,419$-2,830,353$-5,402,686$-13,840,796$-9,498,234
    EBIT$-8,091,348$-10,768,100$-9,807,328$-13,070,613$-6,800,018$-5,640,638$-12,975,112$-12,281,823N/A$-5,475,593$-13,895,818$-9,469,972
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MYNZ

    News

    Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for Mainz Biomed N V Ord Shs (QUCY), detailing its current stock price, market capitalization, and a lack of analyst ratings or specific financial forecast data like EPS...

    TradingKey•8/7/26•Neutral

    Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article from TradingKey provides an earnings forecast for Mainz Biomed N V Ord Shs (QUCY), including anticipated EPS and Revenue growth estimates. It briefly touches on the company's market cap, current stock price...

    TradingKey•7/30/26•Neutral

    Mainz Biomed N V Ord Shs (QUCY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

    This article provides a revenue breakdown for Mainz Biomed N V Ord Shs (QUCY), stating that relevant data for business segments and regional revenue and profit contribution have not yet been disclosed by the company. It...

    TradingKey•7/27/26•Neutral

    QUCY|Mainz Biomed N V Ord Shs|Price:1.095|Chg%:+0.015

    This article provides detailed real-time market data and analysis for Mainz Biomed N V Ord Shs (QUCY) as of July 27, 2026. It includes key financial figures, technical indicators, top shareholders...

    TradingKey•7/27/26•Neutral

    Mainz Biomed N V Ord Shs (QUCY) Balance Sheet

    This article presents the balance sheet for Mainz Biomed N V Ord Shs (QUCY), detailing its assets, liabilities, and shareholders' equity for FY2026Q1. It provides financial figures for current and non-current items...

    TradingKey•7/27/26•Neutral

    MYNZ Valuation and Fair Value

    P/FCF
    -0.1x
    P/B
    1.3x
    See GNG's fair value

    MYNZ Profitability: Margins, ROIC and FCF

    FCF yield
    -888.6%

    MYNZ Competitors

    CompanyTicker
    Sunshine Biopharma IncSBFM
    IO Biotech IncIOBT
    Eocene Ltd.EOCN
    Calidi Biotherapeutics Inc.CLDI
    Eterna Therapeutics IncERNA
    Clearmind Medicine Inc. Common SharesCMND
    Akanda CorpAKAN
    60 Degrees Pharmaceuticals, Inc. Common StockSXTP

    Sector: Healthcare

    MYNZ Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -5.7%

    Frequently Asked Questions About MYNZ

    Does MYNZ pay dividends?

    Mainz Biomed BV (MYNZ) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In